1nql

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
Epidermal growth factor (EGF) receptor is the prototype of the ErbB (HER), family receptor tyrosine kinases (RTKs), which regulate cell growth and, differentiation and are implicated in many human cancers. EGF activates, its receptor by inducing dimerization of the 621 amino acid EGF receptor, extracellular region. We describe the 2.8 A resolution crystal structure, of this entire extracellular region (sEGFR) in an unactivated state. The, structure reveals an autoinhibited configuration, where the dimerization, interface recently identified in activated sEGFR structures is completely, occluded by intramolecular interactions. To activate the receptor, EGF, binding must promote a large domain rearrangement that exposes this, dimerization interface. This contrasts starkly with other RTK activation, mechanisms and suggests new approaches for designing ErbB receptor, antagonists.
+
Epidermal growth factor (EGF) receptor is the prototype of the ErbB (HER) family receptor tyrosine kinases (RTKs), which regulate cell growth and differentiation and are implicated in many human cancers. EGF activates its receptor by inducing dimerization of the 621 amino acid EGF receptor extracellular region. We describe the 2.8 A resolution crystal structure of this entire extracellular region (sEGFR) in an unactivated state. The structure reveals an autoinhibited configuration, where the dimerization interface recently identified in activated sEGFR structures is completely occluded by intramolecular interactions. To activate the receptor, EGF binding must promote a large domain rearrangement that exposes this dimerization interface. This contrasts starkly with other RTK activation mechanisms and suggests new approaches for designing ErbB receptor antagonists.
==Disease==
==Disease==
Line 16: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
-
[[Category: Ferguson, K.M.]]
+
[[Category: Ferguson, K M.]]
-
[[Category: Lemmon, M.A.]]
+
[[Category: Lemmon, M A.]]
[[Category: NAG]]
[[Category: NAG]]
[[Category: auto-inhibition]]
[[Category: auto-inhibition]]
Line 26: Line 26:
[[Category: tyrosine kinase]]
[[Category: tyrosine kinase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:30:30 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:08:58 2008''

Revision as of 12:08, 21 February 2008


1nql, resolution 2.80Å

Drag the structure with the mouse to rotate

Structure of the extracellular domain of human epidermal growth factor (EGF) receptor in an inactive (low pH) complex with EGF.

Contents

Overview

Epidermal growth factor (EGF) receptor is the prototype of the ErbB (HER) family receptor tyrosine kinases (RTKs), which regulate cell growth and differentiation and are implicated in many human cancers. EGF activates its receptor by inducing dimerization of the 621 amino acid EGF receptor extracellular region. We describe the 2.8 A resolution crystal structure of this entire extracellular region (sEGFR) in an unactivated state. The structure reveals an autoinhibited configuration, where the dimerization interface recently identified in activated sEGFR structures is completely occluded by intramolecular interactions. To activate the receptor, EGF binding must promote a large domain rearrangement that exposes this dimerization interface. This contrasts starkly with other RTK activation mechanisms and suggests new approaches for designing ErbB receptor antagonists.

Disease

Known disease associated with this structure: Hypomagnesemia 4, renal OMIM:[131530]

About this Structure

1NQL is a Protein complex structure of sequences from Homo sapiens with as ligand. Full crystallographic information is available from OCA.

Reference

EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization., Ferguson KM, Berger MB, Mendrola JM, Cho HS, Leahy DJ, Lemmon MA, Mol Cell. 2003 Feb;11(2):507-17. PMID:12620237

Page seeded by OCA on Thu Feb 21 14:08:58 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools